Check Lexicon Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$396.1M
EPS (TTM)
-0.1864
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.63%
PE Ratio (TTM)
-3.22
Industry PE ratio
-3.9415151515151514
P/B Ratio
0PEG Ratio
-0.14
EBITDA
-105.5M
Revenue (TTM)
58.4M
Profit Margin
-206.43%
Return On Equity TTM
1829300.00%
Track how Lexicon Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Lexicon Pharmaceuticals, Inc. in the last 5 years
Lowest (12.67x)
June 30, 2021
Industry (-3.94x)
September 18, 2025
Today (-3.22x)
September 18, 2025
Highest (12.67x)
June 30, 2021
Today’s Price to Earnings Ratio: -3.22x
Compare market cap, revenue, PE, and other key metrics of Lexicon Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $396.1M | -32.72% | -3.22 | -206.43% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Lexicon Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lexicon Pharmaceuticals, Inc. investment value today
Current value as on today
₹79,953
Returns
Returns from Lexicon Pharmaceuticals, Inc. Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Lexicon Pharmaceuticals, Inc.. Average target price of $2.75
Get share price movements and forecasts by analysts on Lexicon Pharmaceuticals, Inc..
What analysts predicted
55.27%UPSIDE
Target Price
$2.75
Current Price
$1.23
Analyzed by
11 Analysts
Target
$2.75
Lexicon Pharmaceuticals, Inc. target price $2.75, a slight upside of 55.27% compared to current price of $1.23. According to 11 analysts rating.
Search interest for Lexicon Pharmaceuticals, Inc. Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, -64.81M → 3.25M (in $), with an average increase of 334.4% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 1.26M → 28.86M (in $), with an average increase of 95.6% per quarter
Price Rise
In the last 3 months, LXRX stock has moved up by 46.2%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 170.1%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 101.9%
Organisation | Lexicon Pharmaceuticals, Inc. |
Headquarters | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Industry | Health Technology |
CEO | Dr. Michael S. Exton Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Brian T. Crum | Senior VP, General Counsel & Secretary |
Dr. Craig B. Granowitz M.D., Ph.D. | Senior VP & Chief Medical Officer |
Mr. Scott M. Coiante | Senior VP & CFO |
Mr. Dixon Terry | Vice President of Compliance |
Ms. Desiree Gendron | Vice President of Sales & Training |
Ms. Wendy E. McDermott | Senior Vice President of Human Resources |
Ms. Kristen L. Alexander | Vice President of Finance & Accounting |
Ms. Lisa M. DeFrancesco | Senior Vice President of Investor Relations & Corporate Communications |
Ms. Carrie Siragusa | Vice President of Marketing |
Dr. Michael S. Exton Ph.D. | CEO & Director |
Lexicon Pharmaceuticals, Inc. share price today is $1.23 as on . Lexicon Pharmaceuticals, Inc. share today touched a day high of $1.23 and a low of $1.11.
Lexicon Pharmaceuticals, Inc. share touched a 52 week high of $2.18 on and a 52 week low of $0.28 on . Lexicon Pharmaceuticals, Inc. stock price today i.e. is trending at $1.23,which is 43.45% down from its 52 week high and 333.71% up from its 52 week low.
Lexicon Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Lexicon Pharmaceuticals, Inc. (LXRX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Lexicon Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lexicon Pharmaceuticals, Inc. share’s latest price of $1.23 as on September 18, 2025 at 11:40 pm IST, you will get 8.1301 shares of Lexicon Pharmaceuticals, Inc.. Learn more about
fractional shares .
Lexicon Pharmaceuticals, Inc. stock has given -32.72% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?